Lemborexant

(Dayvigo®)

Dayvigo®

Drug updated on 11/14/2023

Dosage FormTablet (oral: 5 mg, 10 mg)
Drug ClassOrexin receptor antagonists
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.